Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.54 USD | +1.26% | -2.80% | -36.85% |
Financials (USD)
Sales 2024 * | 462M | Sales 2025 * | 526M | Capitalization | 1.09B |
---|---|---|---|---|---|
Net income 2024 * | -36M | Net income 2025 * | -28M | EV / Sales 2024 * | 2.22 x |
Net cash position 2024 * | 63.34M | Net cash position 2025 * | 76.49M | EV / Sales 2025 * | 1.93 x |
P/E ratio 2024 * |
-29
x | P/E ratio 2025 * |
-37.1
x | Employees | 1,200 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.8% |
Latest transcript on AtriCure, Inc.
1 day | +1.26% | ||
1 week | -2.80% | ||
1 month | -6.55% | ||
3 months | -35.54% | ||
6 months | -36.47% | ||
Current year | -36.85% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Carrel
CEO | Chief Executive Officer | 53 | 12-11-01 |
Angela Wirick
DFI | Director of Finance/CFO | 46 | 14-06-30 |
Chief Tech/Sci/R&D Officer | 52 | 17-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Prange
BRD | Director/Board Member | 60 | 19-12-03 |
Michael Carrel
CEO | Chief Executive Officer | 53 | 12-11-01 |
Sven Wehrwein
BRD | Director/Board Member | 73 | 16-11-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 430 M€ | -.--% | ||
0.03% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 22.54 | +1.26% | 704,126 |
24-05-30 | 22.26 | +3.01% | 640,325 |
24-05-29 | 21.61 | -4.68% | 438,915 |
24-05-28 | 22.67 | -2.24% | 507,022 |
24-05-24 | 23.19 | +3.25% | 955,831 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.85% | 1.09B | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.24B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |
- Stock Market
- Equities
- ATRC Stock